Clinical Trial Update: Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer [Phase 1]

View source ↗

Summary

Completed Phase 1 clinical trial evaluating the combination of abemaciclib and niraparib as neoadjuvant therapy before surgery for hormone receptor-positive, HE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• VERZENIO (ABEMACICLIB)
• Zejula (Niraparib)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 | Phase 1 | Status: COMPLETED